Literature DB >> 15942778

The importance of non-invasive genetic analysis in the initial diagnostics of Alport syndrome in young patients.

Maja Slajpah1, Anamarija Meglic, Polonca Furlan, Damjan Glavac.   

Abstract

Alport syndrome is an important hereditary disorder characterized by nephritis and sometimes accompanied by impairment or loss of vision and hearing. The most common form of Alport syndrome is an X-linked dominant trait that has been associated with the gene COL4A5, one of the six types of IV collagen genes. More than 300 different mutations have been identified in the COL4A5 gene, and appear randomly along the whole gene. Three novel mutations, G198E, G3189D and G669R, were found in 5 young patients from 3 different Slovenian families. On the basis of the results of our study and the existing national register of Alport syndrome patients, we demonstrated that non-invasive methods, such as the genetic analysis of collagen genes, particularly in the case of young patients with undefined clinical features, may be of great importance and could diminish the need for invasive skin and renal biopsy. Our study showed the importance of molecular genetic data for the purpose of providing quick and precise diagnoses for affected family members and their offspring, particularly small children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942778     DOI: 10.1007/s00467-005-1975-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

Review 1.  Alport's syndrome.

Authors:  F Flinter
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

Review 2.  Contemporary diagnostic approach in Alport's syndrome.

Authors:  J P Grünfeld
Journal:  Ren Fail       Date:  2000-11       Impact factor: 2.606

Review 3.  Alport disease: a review of the diagnostic difficulties.

Authors:  S Meleg-Smith
Journal:  Ultrastruct Pathol       Date:  2001 May-Jun       Impact factor: 1.094

Review 4.  Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.

Authors:  C E Kashtan
Journal:  Medicine (Baltimore)       Date:  1999-09       Impact factor: 1.889

5.  Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

Authors:  H H Lemmink; W N Nillesen; T Mochizuki; C H Schröder; H G Brunner; B A van Oost; L A Monnens; H J Smeets
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

6.  X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

Authors:  Jean Philippe Jais; Bertrand Knebelmann; Iannis Giatras; Mario DE Marchi; Gianfranco Rizzoni; Alessandra Renieri; Manfred Weber; Oliver Gross; Kai-Olaf Netzer; Frances Flinter; Yves Pirson; Christine Verellen; Jörgen Wieslander; Ulf Persson; Karl Tryggvason; Paula Martin; Jens Michael Hertz; Cornelis Schröder; Marek Sanak; Sarka Krejcova; Maria Fernanda Carvalho; Juan Saus; Corinne Antignac; Hubert Smeets; Marie Claire Gubler
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

7.  Erythrocyte deformability and microhematuria in children and adolescents.

Authors:  Anamarija Meglic; Drago Kuzman; Janez Jazbec; Barbara Japelj-Pavesić; Rajko B Kenda
Journal:  Pediatr Nephrol       Date:  2003-01-17       Impact factor: 3.714

8.  Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling.

Authors:  Oliver Gross; Kai-Olaf Netzer; Romy Lambrecht; Stefan Seibold; Manfred Weber
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

9.  High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing.

Authors:  P Martin; N Heiskari; J Zhou; A Leinonen; T Tumelius; J M Hertz; D Barker; M Gregory; C Atkin; U Styrkarsdottir; H Neumann; J Springate; T Shows; E Pettersson; K Tryggvason
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

10.  X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene.

Authors:  A Renieri; M Bruttini; L Galli; P Zanelli; T Neri; S Rossetti; A Turco; N Heiskari; J Zhou; R Gusmano; L Massella; G Banfi; F Scolari; A Sessa; G Rizzoni; K Tryggvason; P F Pignatti; M Savi; A Ballabio; M De Marchi
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

View more
  4 in total

1.  Is genetic testing of healthy pre-symptomatic children with possible Alport syndrome ethical?

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2006-02-21       Impact factor: 3.714

2.  Diagnosis of Alport syndrome without biopsy?

Authors:  Marie Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-12-02       Impact factor: 3.714

3.  Discordance between skin biopsy and kidney biopsy in an X-linked carrier of Alport syndrome.

Authors:  Lorraine A Hamiwka; David H George; Silviu Grisaru; Julian P Midgley
Journal:  Pediatr Nephrol       Date:  2007-02-10       Impact factor: 3.714

4.  Alport syndrome: significance of gingival biopsy in the initial diagnosis and periodontal evaluation after renal transplantation.

Authors:  Hilal Uslu Toygar; Okan Toygar; Esra Guzeldemir; Ulkem Cilasun; Ahmet Nacar; Nebil Bal
Journal:  J Appl Oral Sci       Date:  2009 Nov-Dec       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.